Skip to main content
Log in

Positive correlation between probucol in low density lipoprotein and LDL-lowering

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The relationship between the content of probucol in plasma and lipid lowering was studied after administration of probucol. The study group consisted of 44 patients with Type II hyperlipidaemia (mean age 56 y).

Total cholesterol level was decreased from 293 to 232 mg · dl−1 by the administration of probucol. The plasma probucol concentration was 2.03 mg · dl−1 after 4 weeks of administration of 500 mg b. d. Although there was no relationship between the change in total cholesterol and the plasma probucol, a linerar relation was observed between the decrease in LDL-cholesterol concentration and the probucol concentration in LDL. Neither the VLDL nor the HDL-probucol content were related to the magnitude of the decrease in lipoprotein cholesterol.

The present study has demonstrated that an increase in the probucol content in LDL was associated with a decrease in plasma LDL-cholesterol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barnhart JW, Rytter JD, Molello JA (1977) An overview of the biochemical pharmacology of probucol. Lipids 12: 29–33

    Google Scholar 

  2. Buckley MMT, Goa KL, Price AH, Brogden RN (1989) Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia. Drugs 37: 761–800

    Google Scholar 

  3. Kesänniemi YA, Grundy SM (1984) Influence of probucol on cholesterol and lipoprotein metabolism in man. J Lipid Res 25: 780–790

    Google Scholar 

  4. Goldberg RB, Mendez A (1988) Probucol enhances cholesterol efflux from cultured human skin fibroblasts. Am J Cardiol 62: 488–518

    Google Scholar 

  5. Li JR, Holets RJ, Kottke BA (1980) Effect of probucol on cholesterol metabolism in the rat. Atherosclerosis 36: 559–565

    Google Scholar 

  6. Marshall FN (1982) Pharmacology and toxicology of probucol. Artery 10: 7–21

    Google Scholar 

  7. Richmond W (1973) Preparation and properties of cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19: 1350–1356

    Google Scholar 

  8. Smith L, Lucas D, Lehmus G (1979) Automated measurement of total cholesterol and triglycerides. In: “Tandem”, on the discrete sample analyzer, Gilford System 3500. Clin Chem 25: 439–442

    Google Scholar 

  9. Goto Y, Akanuma Y, Harano Y, Hata Y, Itakura H, Kajiyama G, Kawade M, Koga S, Kuzuya F, Maruhama Y, Matsuzawa Y, Murai A, Murase T, Naito C, Nakai T, Noma A, Saito Y, Sasaki J, Takeuchi N, Tamachi H, Uzawa H, Yamamoto A, Yamazaki S, Yasugi T, Yukawa S (1986) Determination by the SRID method of normal values of serum apo-lipoproteins (A-I, A-II, B, C-III and E) in normolipidemic healthy Japanese subjects. J Clin Biochem Nutr 1: 73–88

    Google Scholar 

  10. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353

    Google Scholar 

  11. Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15: 212–216

    Google Scholar 

  12. Dachet C, Jacotot B, Buxtorf JC (1985) The hypolipidemic action of probucol. Atherosclerosis 58: 261–268

    Google Scholar 

  13. Sudo K, Midorikawa K, Tachizawa H, Hata Y, Saito Y (1983) Studies on the distribution of probucol in human serum lipoprotein fractions. Jpn J Atheroscler 11: 591–595

    Google Scholar 

  14. Urien S, Riant P, Albeugres E, Brioude R, Tillement JP (1984) In vitro studies on the probucol distribution of probucol among human plasma lipoproteins. Mol Pharmacol 26: 322–327

    Google Scholar 

  15. Felin R, Gasparotto A, Valerio G, Baiocchi MR, Pardrini R, Lamon S, Vitale E, Baggio G, Crepaldi G (1986) Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia. Atherosclerosis 59: 47–56

    Google Scholar 

  16. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D (1986) Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 77: 641–644

    Google Scholar 

  17. Reaven PD, Parthasarathy S, Beltz WF, Witztum JL (1992) Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans. Arterioscler Thromb 12: 318–324

    Google Scholar 

  18. Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Rezzonico L, Chiesa G, Sirtori CR (1989) Mechanism of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer. Arterioscler Throm 9: 462–469

    Google Scholar 

  19. Chiesa G, Franceschini G, Sirtori CR (1990) In vivo activity of probucol on cholesteryl ester transport. Biophys Biochim Acta 1045: 302–304

    Google Scholar 

  20. Naruszewicz M, Carew TE, Pittman RC, Witztum JL, Steinberg D (1984) A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. J Lipid Res 25: 1206–1213

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shinomiya, M., Shirai, K., Saito, Y. et al. Positive correlation between probucol in low density lipoprotein and LDL-lowering. Eur J Clin Pharmacol 45, 343–346 (1993). https://doi.org/10.1007/BF00265952

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00265952

Key words

Navigation